Isracann Biosciences Launches Phase One Facility Development Program in Israel
28. Oktober 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is...